US 11179400
Heterocyclic compounds as RSV inhibitors
granted A61KA61K31/55A61K45/00
Quick answer
US patent 11179400 (Heterocyclic compounds as RSV inhibitors) held by Enanta Pharmaceuticals, Inc. expires Mon Nov 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue Nov 23 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 18 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/55, A61K45/00, A61K45/06, A61P